CYCLOMEN
CYCLOMEN
Approved
DIN Number
02018160
Drug Class
Human
Market Date
Dec 31, 1972
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02018160
AIG Number0110952001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03XA01 DANAZOL
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification68:08.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DANAZOLActive
Strength: 200 MG
Monograph: DANAZOL